Related Experiment Video

Updated: Oct 26, 2025

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

25.8K

Statin Therapy and Intensity: Prognosis in Patients with Myocardial Injury

Erik Kadesjö1, Andreas Roos1, Anwar J Siddiqui1

  • 1Department of Medicine, Karolinska Institutet, Solna, Stockholm, Sweden; Department of Emergency and Reparative Medicine, Karolinska University Hospital, Huddinge, Stockholm, Sweden.

The American Journal of Medicine
|August 3, 2021
PubMed

Insights

High-intensity statin therapy may benefit patients with myocardial injury, but results were not statistically significant. Further research is needed to confirm the impact of statins on myocardial injury mortality.

Area of Science:

  • Cardiology
  • Pharmacology
  • Clinical Research

Background:

  • No established pharmacological therapy exists for myocardial injury without type 1 myocardial infarction.
  • This study investigates the impact of statin treatment on patients experiencing myocardial injury.

Purpose of the Study:

  • To evaluate the association between statin intensity and mortality in patients with various types of myocardial injury.
  • To determine if high-intensity statin therapy offers a survival benefit in myocardial injury patients.

Main Methods:

  • Retrospective analysis of 2054 patients with myocardial injury (acute, chronic, type 2 myocardial infarction) and type 1 myocardial infarction.
  • Patients were categorized by statin intensity (low, moderate, high) based on dispensed prescriptions.
  • Adjusted hazard ratios for all-cause mortality were calculated.

Main Results:

  • High-intensity statin use was low across all myocardial injury groups (13-30%).
  • Adjusted mortality rates were higher in acute/chronic myocardial injury compared to type 1 myocardial infarction.
  • In type 1 myocardial infarction, high-intensity statins showed a non-significant 20% mortality risk reduction.

Conclusions:

  • High-intensity statin treatment may potentially benefit patients with myocardial injury.
  • The observed associations between statin intensity and mortality were not statistically significant after adjusting for confounders.
  • Further investigation is warranted to confirm the role of statins in managing myocardial injury.
Abstract

Keywords:
Cardiac biomarkerMyocardial infarctionMyocardial injuryStatinTroponin

More Related Videos

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

9.4K
Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy07:40

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy

Published on: May 26, 2023

1.4K

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
62
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
37
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
168
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
53
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
63
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
77